Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases

Front Pharmacol. 2022 Oct 4:13:1041576. doi: 10.3389/fphar.2022.1041576. eCollection 2022.

Md Jamal Uddin^{1

2}, Md Abdul Hannan^{1

3}, Md Ataur Rahman^{1

4

5}, Nadezda Apostolova^{6

7}

¹ ABEx Bio-Research Center, East Azampur, Dhaka, Bangladesh.
² Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, South Korea.
³ Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh, Bangladesh.
⁴ Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemungu, Seoul, South Korea.
⁵ Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul, South Korea.
⁶ Department of Pharmacology, University of Valencia-CIBERehd, Valencia, Spain.
⁷ Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain.

No abstract available

Keywords: DNA damage; and novel therapeutics; brain disorders; cancers; kidney disease; mitochondrial dysfunction; oxidative stress.

Publication types